Ayurcann posts 25% sales growth in second quarter, projects C$50M revenue in 2025

https://s43720.pcdn.co/wp-content/uploads/2024/05/ayurcann1.jpg

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) reported record sales for its fiscal second quarter, as it tries to narrow its losses after cancelling a merger in November.

The Canadian cannabis manufacturer posted C$13.4 million in gross revenue for the three months that ended Dec. 31, a 25% rise from the…

Please login to read all 297 words.

Leave a Reply

Your email address will not be published. Required fields are marked *